Rotavirus vaccines: considerations for successful implementation in Europe

A group of European experts in infectious diseases and vaccinology has met on several occasions to assess the rationale for universal vaccination against rotavirus infection of infants in Europe. On the basis of the available data, we concluded that vaccination was the best approach to prevent sever...

Full description

Saved in:
Bibliographic Details
Published inThe Lancet infectious diseases Vol. 6; no. 12; pp. 805 - 812
Main Authors Van Damme, Pierre, Van der Wielen, Marie, Ansaldi, Filippo, Desgrandchamps, Daniel, Domingo, Javier Diez, Sanchez, Francisco Gimenez, Gray, Jim, Haditsch, Martin, Johansen, Kari, Lorgelly, Paula, Lorrot, Mathie, Parez, Nathalie, Reschke, Volkmar, Rose, Markus
Format Journal Article
LanguageEnglish
Published London Elsevier Ltd 01.12.2006
Lancet Publishing Group
Elsevier Limited
Subjects
Biological and medical sciences
Europe
Gastroenteritis
Gastroenteritis - prevention & control
Gastroenteritis - virology
Human viral diseases
Humans
Immunization
Infant
Infectious diseases
Mass Vaccination - economics
Mass Vaccination - organization & administration
Medical sciences
Population Surveillance
Rotavirus Infections - prevention & control
Rotavirus Vaccines - therapeutic use
Vaccines
Viral diseases
Viral diseases of the digestive system
Europe
Virus
Human
Prevention
Immunoprophylaxis
Rotavirus
Gastroenteritis
Digestive diseases
Intestinal disease
Vaccine
Reoviridae
Implementation
Gastric disease
Online AccessGet full text

Cover

More Information
Summary:A group of European experts in infectious diseases and vaccinology has met on several occasions to assess the rationale for universal vaccination against rotavirus infection of infants in Europe. On the basis of the available data, we concluded that vaccination was the best approach to prevent severe rotavirus gastroenteritis, and that European countries should consider implementing rotavirus vaccination in their routine immunisation programmes. The main barrier to the implementation of rotavirus vaccination in Europe is a general lack of awareness of stakeholders, policymakers, health-care professionals, and parents about rotavirus disease and the advantages of vaccination. Further studies on the cost of the disease and the benefit of vaccination, together with raising awareness are necessary steps to ensure successful implementation of rotavirus vaccination in Europe.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1473-3099
1474-4457
DOI:10.1016/S1473-3099(06)70657-0